In vitro lymphocyte proliferative responses and gamma-interferon production as measures of cell-mediated immunity of cattle exposed to Pasteurella haemolytica.
Cell-mediated immune mechanisms may play a role in the pathogenesis and prevention of pneumonia in cattle caused by Pasteurella haemolytica serotype A1. To determine the circumstances required to stimulate and identify cell-mediated immune responses, calves were vaccinated with a commercial P. haemolytica bacterin or a live commercial P. haemolytica vaccine, or were infected intratracheally with virulent P. haemolytica. All calves were challenge-exposed intratracheally with P. haemolytica 31 d after vaccination or prior infection. Peripheral blood mononuclear cells and mediastinal and superficial cervical lymph node cells were stimulated with antigens prepared from P. haemolytica to evaluate in vitro proliferative responses and gamma-interferon production as measures of cell-mediated immunity. Strong proliferative responses and gamma-interferon production were detected in lymph node cells from calves vaccinated with the live vaccine and from infected calves, especially in response to stimulation with an outer membrane protein preparation from P. haemolytica. Greater proliferative responses and gamma-interferon production were associated with the lymph node nearer the site of bacterin administration (superficial cervical lymph node) or the site of infection (mediastinal lymph node), whereas greater proliferative responses and gamma-interferon production were associated with the more distant lymph node (mediastinal lymph node) in calves vaccinated with the live vaccine. Neither proliferative responses nor gamma-interferon production were detected in peripheral blood mononuclear cells from calves that were vaccinated for or infected with P. haemolytica. Antileukotoxin antibody titers were determined by a serum neutralization assay, and protection against pneumonic lesions was more closely correlated with antileukotoxin antibody responses than with lymphocyte proliferation or gamma-interferon responses.
Respiratory Disease Research Unit, USDA, ARS, National Animal Disease Center, Ames, Iowa, USA.
B M
BM
DeBey
J A
JA
Roth
K A
KA
Brogden
R C
RC
Cutlip
M G
MG
Stevens
T
T
Jones
R E
RE
Briggs
J P
JP
Kluge
D000818:Animals; D000907:Antibodies, Bacterial / Q000276:immunology / Q000378:metabolism; D000942:Antigens, Bacterial / Q000276:immunology / Q000378:metabolism / Q000494:pharmacology; D002417:Cattle / Q000276:immunology*; D002418:Cattle Diseases / Q000276:immunology* / Q000473:pathology / Q000517:prevention & control*; D002455:Cell Division / Q000502:physiology; D004797:Enzyme-Linked Immunosorbent Assay / Q000662:veterinary; D005098:Exotoxins / Q000276:immunology; D007111:Immunity, Cellular / Q000276:immunology*; D066298:In Vitro Techniques; D007371:Interferon-gamma / Q000378:metabolism*; D008198:Lymph Nodes / Q000378:metabolism / Q000473:pathology; D008214:Lymphocytes / Q000378:metabolism / Q000473:pathology*; D016978:Mannheimia haemolytica / Q000276:immunology* / Q000378:metabolism; D010326:Pasteurella Infections / Q000276:immunology / Q000517:prevention & control / Q000662:veterinary*; D014613:Vaccines, Attenuated / Q000276:immunology / Q000494:pharmacology
D000907:Antibodies, Bacterial; D000942:Antigens, Bacterial; D005098:Exotoxins; D014613:Vaccines, Attenuated; C018579:leukotoxin; D007371:Interferon-gamma